Studi sull\u2019accuratezza numerica di un solutore meshfree per l\u2019approssimazione di campi

L\u2019attivit\ue0 di ricerca \ue8 stata finalizzata allo studio di metodologie numeriche avanzate senza reticolazioni per l\u2019approssimazione di funzioni e sue derivate. In particolare si sono condotti studi sull\u2019accuratezza e convergenza del metodo Smoothed Particle Hydrodynamics riferendosi a campionamenti regolari e no

An Improved Solver for the M/EEG Forward Problem

Noninvasive investigation of the brain activity via electroencephalography (EEG) and magnetoencephalography (MEG) involves a typical inverse problem whose solution process requires an accurate and fast forward solver. We propose the Method of Fundamental Solutions (MFS) as a truly meshfree alternative to the Boundary Element Method (BEM) for solving the M/EEG forward problem. The solution of the forward problem is obtained, via the Method of Particular Solutions (MPS), by numerically solving a set of coupled boundary value problems for the 3D Laplace equation. Numerical accuracy and computational load are investigated for spherical geometries and comparisons with a state-of-the-art BEM solver shows that the proposed method is competitive

IL METODO DELLE SOLUZIONI FONDAMENTALI PER LA SOLUZIONE DEL PROBLEMA DIRETTO M/EEG

The research already started on the mesh-free solution of the M / EEG direct problem has led to the development of a solver based on the method of fundamental solutions (MFS, method of fundamental solutions) able to manage the physical-geometric complexity of realistic models of the head more efficiently than traditional

Peripheral Arterial Tonometry to Measure the Effects of Vardenafil on Sympathetic Tone in Men with Lifelong Premature Ejaculation

To elucidate whether adrenergic overtone is involved in the pathophysiology of men with lifelong (LL) premature ejaculation (PE), we investigated differences in reactive hyperemia index (RHI) responses by using peripheral arterial tonometry (PAT). 20 men with LL-PE (18–40 years) were enrolled in an 8-week, double-blind, placebo-controlled, crossover study and compared with 10 age-matched controls without LL-PE. Primary endpoints were PAT modifications induced by vardenafil 10 mg on demand. Secondary endpoints were the improvement in intravaginal ejaculatory latency time (IELT) as measured by the stopwatch technique and variations in anxiety scores at Stai-X1 for state-anxiety and Stai-X2 for trait-anxiety. At baseline, men with LL-PE showed higher RHI variation (), Stai-X1 and Stai X2 scores (, resp.), and prolactin levels () compared with controls. Vardenafil treatment markedly reduced RHI variation in men with LL-PE () when compared with placebo. Mean changes in geometric IELT were higher after taking vardenafil (0.6 ± 0.3 versus 4.5 ± 1.1 min, ) when compared with placebo. STAI-X1 and STAI-X2 scores fell within the normal range after treatment with vardenafil (). Vardenafil was an effective treatment in men with LL-PE; improvements of IELT may be due to increased NO production which is able to reduce adrenergic overactivity and anxiety levels

The GiSAS study: Rationale and design of pragmatic randomized controlled trial on aripiprazole, olanzapine and haloperidol in the long-term treatment of schizophrenia

Given the controversy about the comparative efficacy of first- compared with second-generation antipsychotics in the treatment of schizophrenia, more large-scale evidence is needed to guide clinicians in their prescriptions. Most randomized controlled trials (RCTs) were conducted in centers of excellence on highly selected samples, poorly representative of real-world patients, and often suffered conflicts of interest as they were sponsored by drug companies. The primary aim of the present study is to compare the effectiveness of haloperidol, olanzapine and aripiprazole in a representative sample of schizophrenia patients. The GiSAS trial is an open-label, independent, pragmatic RCT in Italian community-based public psychiatric services. At least 260 patients meeting the DSM-IV criteria for schizophrenia will be randomly allocated to one of the study drugs and followed up for one year. A two-year observational phase will follow. The primary outcome for tolerability will be the onset of metabolic syndrome. The primary endpoint for effectiveness will be discontinuation of antipsychotic monotherapy. Secondary measures include global functioning, time to discontinuation due to side-effects, change of lipid profile, extrapyramidal symptoms and other adverse effects. In the last four years, the GiSAS study group has been working to implement this multicenter RCT. The trial mechanism is now fully functional and working. As of end of February 2011, 260 subjects were randomized by 54 study investigators in 33 out of 43 participating centers

Tadalafil modulates aromatase activity and androgen receptor expression in a human osteoblastic cell in vitro model

Purpose Phosphodiesterase type-5 inhibitor (PDE5i) tadalafil administration in men with erectile dysfunction is associated with increased testosterone/estradiol ratio, leading to hypothesize a potential increased effect of androgen action on target tissues. We aimed to characterize, in a cellular model system in vitro, the potential modulation of aromatase and sex steroid hormone receptors upon exposure to tadalafil (TAD). Methods Human osteoblast-like cells SAOS-2 were chosen as an in vitro model system since osteoblasts are target of steroid hormones. Cells were tested for viability upon TAD exposure, which increased cell proliferation. Then, cells were treated with/without TAD for several times to evaluate potential modulation in PDE5, aromatase (ARO), androgen (AR) and estrogen (ER) receptor expression. Results Osteoblasts express significant levels of both PDE5 mRNA and protein. Exposure of cells to increasing concentrations of TAD (10−8–10−7 M) decreased PDE5 mRNA and protein expression. Also, TAD inhibited ARO mRNA and protein expression leading to an increase in testosterone levels in the supernatants. Interestingly, TAD increased total AR mRNA and protein expression and decreased ERα, with an increased ratio of AR/ER, suggesting preferential androgenic vs estrogenic pathway activation. Conclusions Our results demonstrate for the first time that TAD decreases ARO expression and increases AR protein expression in human SAOS-2, strongly suggesting a new control of steroid hormones pathway by PDE5i. These findings might represent the first evidence of translational actions of PDE5i on AR, which leads to hypothesize a growing relevance of this molecule in men with prostate cancer long-term treated with TAD for sexual rehabilitation. Keywords Tadalafil · Osteoblasts · Aromatase · Androgen receptor · Estrogen recepto

STIMA DEL POTENZIALE ELETTRICO IN tDCS CON APPROCCIO MESHLESS INNOVATIVO

Transcranial DC stimulation (transcranial Direct Current Stimulation, tDCS) is a non-invasive technique aimed at modifying neuronal activity for the purpose therapeutic and / or for the improvement of mental performance. A continuous current of entity modest (below the threshold of perception) is injected into the brain via electrodes placed on the scalp surface to produce changes in long-term cortical activity. Despite the increasing use of this and other similar techniques, and the relevant ones applications - for example in the field of neuropsychological rehabilitation - their impact on neuronal activity is not yet fully known, mainly due to the difficulty of predict the spatial distribution of the current within the brain, and to determine the optimal position and size of the electrodes

A Meshfree Solver for the MEG Forward Problem

Noninvasive estimation of brain activity via magnetoencephalography (MEG) involves an inverse problem whose solution requires an accurate and fast forward solver. To this end, we propose the Method of Fundamental Solutions (MFS) as a meshfree alternative to the Boundary Element Method (BEM). The solution of the MEG forward problem is obtained, via the Method of Particular Solutions (MPS), by numerically solving a boundary value problem for the electric scalar potential, derived from the quasi-stationary approximation of Maxwell’s equations. The magnetic field is then computed by the Biot-Savart law. Numerical experiments have been carried out in a realistic single-shell head geometry. The proposed solver is compared with a state-of-the-art BEM solver. A good agreement and a reduced computational load show the attractiveness of the meshfree approach

ADVANCED BIO-ELECTROMAGNETIC NUMERICAL MODELLING AND ICT FOR HUMAN BRAIN RESEARCH

Functional imaging is used in the research area neurological, neurophysiology and cognitive psychology, for the diagnosis of diseases metabolic and for the detection of thin / squamous lesions (eg Alzheimer's disease) and for the development of neural interfaces (brain-computer interfaces - BCI)